These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6062099)
21. MRSA in the hospital setting: prevention is the best cure. Brown P; Abraham C J Ark Med Soc; 2008 Jul; 105(1):12-3. PubMed ID: 18630195 [No Abstract] [Full Text] [Related]
22. [Theoretical substantiation of methods for limiting the circulation of drug-resistant staphylococci]. Zueva VS Antibiotiki; 1984 Apr; 29(4):299-311. PubMed ID: 6378082 [No Abstract] [Full Text] [Related]
23. MRSA: time to prevent as well as control. Dunaway ER Nurs Manage; 2008 Jun; 39(6):49-53. PubMed ID: 18536591 [No Abstract] [Full Text] [Related]
25. [Reasonable hospital use of mupirocin]. Lucet J; Descamps V Ann Dermatol Venereol; 2000 Apr; 127(4):365-6. PubMed ID: 10844254 [No Abstract] [Full Text] [Related]
26. Prevention and control of methicillin-resistant Staphylococcus aureus. Gleeson TD Dis Mon; 2008 Dec; 54(12):801-6. PubMed ID: 18996283 [No Abstract] [Full Text] [Related]
27. [How promising is decontamination treatment of MRSA carriers?]. Panknin HT Med Monatsschr Pharm; 2007 Mar; 30(3):114-5. PubMed ID: 17405489 [No Abstract] [Full Text] [Related]
28. [Shunt sepsis. On the clinical aspects of septic complications of intermittent hemodialysis]. Stille W; Brass H; Hach W; Renner D; Heintz R Dtsch Med Wochenschr; 1967 Mar; 92(11):467-72. PubMed ID: 6019682 [No Abstract] [Full Text] [Related]
29. Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus. Srinivasan S; Sheela D; ; Mathew R; Bazroy J; Kanungo R Indian J Med Microbiol; 2006 Jul; 24(3):182-5. PubMed ID: 16912437 [TBL] [Abstract][Full Text] [Related]
30. Management and prevention of infections due to gram-positive cocci in intensive care units. Graninger W; Kurz R; Schneeweiss B; Janata O Br J Clin Pract Suppl; 1988 Feb; 57():91-9. PubMed ID: 3140886 [No Abstract] [Full Text] [Related]
34. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units. Humphreys H; Smyth EG J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985 [No Abstract] [Full Text] [Related]
35. Living on borrowed time. Carlowe J Nurs Stand; 2003 Nov 12-18; 18(9):18-9. PubMed ID: 14649189 [No Abstract] [Full Text] [Related]
37. Bad bugs. What you need to know about VRE/MRSA. Lejeune JR; Berkowitz DM JEMS; 2000 Dec; 25(12):56-61; quiz 62. PubMed ID: 11138384 [No Abstract] [Full Text] [Related]
38. Germ warfare. A drug-resistant staph strain has doctors on edge. Gorman C Time; 1997 Sep; 150(9):65. PubMed ID: 10173227 [No Abstract] [Full Text] [Related]
39. Improving hospital policy. Gibbs H Nurs Times; 1995 Nov 1-7; 91(44):28-9. PubMed ID: 7501516 [TBL] [Abstract][Full Text] [Related]
40. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Gould IM Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]